BioHealth News
BISNOW: In Nation’s Tightest Life Sciences Market, There Is Little Appetite To Build More Space
February 1, 2024 Emily Wishingrad - The life sciences real estate train, which just a few years ago was reaching top speeds, is now pressing down firmly on the brakes. …
Read More
Baltimore Banner: One biotech company is leaving, one is staying. What does that say about Baltimore?
Meredith Cohn - 2/6/2024 - Thrive Earlier Detection Corp., a startup company based on early cancer testing technology developed at the Johns Hopkins University, was snatched up…
Read More
WBJ: AstraZeneca doubles down on Montgomery County with $300M investment
By Sara Gilgore – Staff Reporter, Washington Business Journal - AstraZeneca PLC (NYSE: AZN) is leaving no doubt about its commitment to Montgomery County, pouring $300 million…
Read More
GEN: Novo Holdings Buys Catalent for $16.5B; Sells Three Sites to Novo Nordisk for $11B
By Alex Philippidis -February 5, 2024 - Novo Holdings, the asset manager of the foundation that controls Novo Nordisk, has agreed to acquire contract development…
Read More
J.P. Morgan Releases 2024 Innovation Economy Outlook: What’s Next for Venture Capital?
J.P. Morgan has released its 2024 Innovation Economy Outlook, offering valuable insights for those interested in the future of venture capital, investment trends, and…
Read More
BioHealth Innovation, Inc. (BHI) Welcomes Yaminah Leggett-Wells, Senior Director, Alliance Management at Amgen as Newest Member of the Board of Directors
ROCKVILLE, MARYLAND, February 5, 2024 – BioHealth Innovation, Inc. (BHI), a leading public-private nonprofit organization dedicated to advancing healthcare innovation in the BioHealth Capital…
Read More
Bio: House passes bill restoring full R&D expensing
On January 31, the House passed legislation to restore the immediate expensing of R&D expenses. The Biotechnology Innovation Organization (BIO) has long advocated for…
Read More
Maxim Biomedical, Inc. Secures Second NIH RADx Tech High Performance Award for Continued Development of At-Home FiarFly™ Reader and COVID-19 & Flu A/B Rapid Test
ROCKVILLE, Md., Feb. 1, 2024 /PRNewswire/ -- MaximBio, a leading innovator in next-generation healthcare diagnostic technologies, is pleased to announce that it has been granted a…
Read More
U.S. FDA Grants Theradaptive IDE Approval For Phase I/II Clinical Trials
Global study will assess the safety and efficacy of the company's lead spinal fusion product, OsteoAdapt SP FREDERICK, Md., Feb. 1, 2024 /PRNewswire/ -- Theradaptive, the market…
Read More
BioBuzz: Virginia Bio-Connect – The Success of Virginia’s First Statewide Collaborative Life Sciences Initiative
By Jelena Ivanjac | January 30, 2024 - The end of 2023 marked the completion of Virginia’s first statewide life sciences initiative, Virginia Bio-Connect, which started in April…
Read More
Baltimore’s LifeSprout Enters into Licensing Agreement with Boyang Trading to Develop and Commercialize Next-Generation Lumina™ Dermal Filler in Greater China
BALTIMORE, Jan. 31, 2024 /PRNewswire/ -- LifeSprout, a privately held regenerative medicine company founded with technology licensed from Johns Hopkins University, today announced it has entered…
Read More
GEN: Top 10 Biopharma Takeover Targets of 2024
By Alex Philippidis - February 1, 2024 - Viewed simply by numbers of merger and acquisition (M&A) deals, 2023 was a down year: 1,078 biotech companies found buyers…
Read More
Deadline Approaching: Apply to Be Part of the Maryland Delegation at BIO 2024
The Maryland Department of Commerce invites companies to seize the opportunity to join the Maryland delegation at the BIO International Convention in San Diego,…
Read More
FDA Grants Orphan Drug Designation (ODD) Status to NeoImmuneTech’s NT-I7 for Advanced Pancreatic Cancer Treatment
ROCKVILLE, Md., Jan. 30, 2024 /PRNewswire/ -- NeoImmuneTech, Inc. (NIT), a T cell-focused therapeutics company, today announced that the U.S. Food and Drug Administration (FDA) has…
Read More
Infinity Bio Launches Next-Generation Antibody Profiling Platform Utilizing MIPSA Technology
BALTIMORE--(BUSINESS WIRE)--Infinity Bio, Inc. announces its new antibody profiling platform, leveraging Molecular Indexing of Proteins by Self-Assembly (MIPSA) technology. This platform offers unparalleled depth…
Read More